Issues
Volume 217 Issue 4
News
News briefs
COVID‐19 fuels largest backslide in vaccinations in three decades The largest sustained decline in childhood vaccinations in approximately 30years has been recorded in official data published by the WHO and UNICEF. The percentage of children who received three doses of the vaccine against diphtheria, tetanus and pertussis (DTP3) — a marker for immunisation coverage within and across countries — fell 5 percentage points between 2019 and 2021 to 81%. As a result, 25 million children missed out on one or more doses of DTP through routine immunisation services in 2021 alone. This is 2 million more than those who missed out in 2020 and 6 million more than in 2019, highlighting the growing number of children at risk from devastating but preventable diseases. The decline was due to many factors including an increased number of children living in conflict and fragile settings where immunisation access is often challenging, increased misinformation and coronavirus disease 2019 (COVID‐19)‐related issues such as service and supply chain disruptions, resource diversion to response efforts, and containment measures that limited immunisation service access and availability. Eighteen million of the 25 million children did not receive a single dose of DTP during the year, most of whom live in low and middle‐income countries, with India, Nigeria, Indonesia, Ethiopia and the Philippines recording the highest numbers. Among countries with the largest relative increases in the number of children who did not receive a single vaccine between 2019 and 2021 are Myanmar and Mozambique. Globally, over a quarter of the coverage of human papillomavirus (HPV) vaccines that was achieved in 2019 has been lost. This has grave consequences for the health of women and girls, as global coverage of the first dose of HPV vaccine is only 15%, despite the first vaccines being licensed over 15years ago. This historic backsliding in rates of immunisation is happening against a backdrop of rapidly rising rates of severe acute malnutrition. A malnourished child already has weakened immunity, and missed vaccinations can mean common childhood illnesses quickly become lethal to them. The convergence of a hunger crisis with a growing immunisation gap threatens to create the conditions for a child survival crisis. https://data.unicef.org/topic/child‐health/immunization/ https://immunizationdata.who.int/ No health benefits in alcohol for under 40s, but small amount may benefit older people Young people face higher health risks from alcohol consumption than older adults, according to a new analysis published in The Lancet. The study suggests that global alcohol consumption recommendations should be based on age and location, with the strictest guidelines targeted toward males aged 15–39years, who are at the greatest risk of harmful alcohol consumption worldwide. The research also indicates that adults aged 40years and older without underlying health conditions may see some benefits from small alcohol consumption (between one and two standard drinks per day), including a reduced risk in cardiovascular disease, stroke and diabetes. Using estimates of alcohol use in 204 countries, researchers calculated that 1.34 billion people consumed harmful amounts in 2020. In every region, the largest segment of the population drinking unsafe amounts of alcohol were males aged 15–39years and for this age group, drinking alcohol does not provide any health benefits and presents many health risks, with 60% of alcohol‐related injuries occurring among people in this age group, including motor vehicle accidents, suicides and homicides. The researchers looked at the risk of alcohol consumption on 22 health outcomes, including injuries, cardiovascular diseases, and cancers using 2020 Global Burden of Disease data for males and females aged 15–95years and older between 1990 and 2020, in 204 countries and territories. The recommended amount of alcohol for people aged 15–39years before risking health loss was 0.136 standard drinks per day (a little more than one‐tenth of a standard drink). That amount was slightly higher for females aged 15–39years at 0.273 drinks (about a quarter of a standard drink per day). One standard drink is defined as 10g of pure alcohol, which is equivalent to a small glass of red wine (100mL or 3.4floz) at 13% alcohol by volume, a can or bottle of beer (375mL or 12floz) at 3.5% alcohol by volume, or a shot of whiskey or other spirits (30mL or 1.0floz) at 40% alcohol by volume. https://www.thelancet.com/journals/lancet/article/PIIS0140‐6736(22)00847‐9/fulltextdoi:10.5694/mja2.51668
Perspectives
Making everyone count: it is time to improve the visibility of people with disability in primary care
Without data on access to, or quality of, the care for people with disability, it is impossible to determine drivers of health inequities, and to develop evidence-informed policies to improve care and track progress towards reducing health inequities
Jodie Bailie · Nicola Fortune · Julie Gordon · Richard C Madden · Gwynnyth Llewellyn
More than a fleeting conversation: managing medication communication across transitions of care
Fostering engagement among older patients and families and creating opportunities for decision making about medications are crucial for improved safety and quality across transitions of care
Elizabeth Manias · Carmel Hughes · Robyn E Woodward‐Kron · Christine M Jorm · Guncag Ozavci · Tracey K Bucknall
Voluntary assisted dying: estimating life expectancy to determine eligibility
Assessing a person’s eligibility for VAD is difficult because prognostication is difficult, prognosis is inherently uncertain, and the eligibility criteria are not clearly specified
Sharon H Nahm · Martin R Stockler · Belinda E Kiely
What causes multiple sclerosis? Getting closer to the answers
MS risk is becoming less of a mystery as we gain a better understanding of its causes
Bruce V Taylor
Medical education
Microangiopathic haemolytic anaemia: a rare first presentation of lung cancer
A 76-year-old woman with no significant medical history presented to hospital after 3 days of vomiting
Nicholas M Stacey · Martin Feddersen
An orf‐ful site
An otherwise well 45-year-old sheep farmer presented to her general practitioner following a one-week history of tender reddish-blue nodules on the dorsal surface of her left hand
Joshua Farrell · Thomas J Stewart
Editorials
The impact of the MJA continues its rise
During times of medical crisis, reputable general medical journals are needed more than ever
Nicholas J Talley
Vaccine safety: what systems are required to ensure public confidence in vaccines?
No single surveillance system is perfect, but integrating data from multiple sources can provide comprehensive and reliable signal detection
Allen C Cheng · Jim P Buttery
Is D‐dimer the new test for venom‐induced consumption coagulopathy after snakebite?
Despite its potential value, a number of questions require answers before its role in clinical practice becomes clear
Mark Little
Is Australia ready for monkeypox?
The Australian health system can respond effectively to monkeypox, especially with good surveillance, testing and tracing and rapidly procuring third generation vaccines and antivirals
C Raina MacIntyre · Andrew E Grulich
Research
The short term safety of COVID‐19 vaccines in Australia: AusVaxSafety active surveillance, February – August 2021
AusVaxSafety active surveillance affirms the short term safety of Comirnaty and Vaxzevria vaccines in a large population sample
Lucy Deng · Catherine Glover · Michael Dymock · Alexis Pillsbury · Julie A Marsh · Helen E Quinn · Alan Leeb · Patrick Cashman · Thomas L Snelling · Nicholas Wood · Kristine Macartney
D-dimer testing for early detection of venom-induced consumption coagulopathy after snakebite in Australia (ASP-29)
Quantitative D-dimer assessment 2‒6 hours after snakebite could aid early diagnosis of envenoming with venom-induced consumption coagulopathy
Geoffrey K Isbister · Tina Noutsos · Shane Jenkins · Katherine Z Isoardi · Jessamine Soderstrom · Nicholas A Buckley
Research letters
Sentinel lymph node biopsy rates in Victoria, 2018 and 2019
The optimal use of online risk tools in practice and barriers to patient access should be investigated
Australian Melanoma Centre of Research Excellence Study Group
Infant feeding patterns before and after changes to food allergy prevention guidelines in Australia
Timely introduction of allergens did not reduce breastfeeding or increase extremely early introduction to solid foods
Jennifer Koplin · Victoria Soriano · Merryn Netting · Rachel Peters
Consensus statement
Consensus statement on the current pharmacological prevention and management of heart failure
New recommendations for the pharmacological management of heart failure
Andrew P Sindone · Carmine De Pasquale · John Amerena · Christine Burdeniuk · Alicia Chan · Andrew Coats · David L Hare · Peter Macdonald · Aaron Sverdlov · John J Atherton
Letters
Social and occupational outcomes for young people who attend early intervention mental health services: a longitudinal study
To the Editor: The article by Iorfino and colleagues1 presents interesting follow‐up data on young people attending two mental health clinics. For 1510 of 2901 young people who presented in 2008–2018 with anxiety, mood or psychotic disorders, the authors identified trajectories in social and occupational functioning over 2years. Iorfino and colleagues describe the model as “primary care‐based” and “low intensity”, but it is neither generalist primary care nor low intensity as it comprises headspace plus specialised services and hospitalisation if needed. Several limitations, including 48% of patients excluded and the lack of a comparison group, make any conclusions problematic. Box 3 suggests little average change, but a latent class analysis suggests that one‐third participants who were well functioning at baseline had good functional outcomes, while the remaining two‐thirds “had generally poor functional outcome patterns”. The data are compatible with a range of conclusions, including “findings suggest that employment and engagement in education and training are protective” or “the treatment model makes no discernible difference to young people’s social and occupational functioning”. Yet Iorfino and colleagues claim that “findings suggest that the current primary care‐based model meets the needs of only a minority of young people seeking care” and call for “more comprehensive and multidisciplinary approaches because of substantial comorbidity, ambiguous or attenuated symptomatology”. This sounds like general practice, where undifferentiated illness and multimorbidity are the norm. Contrary to Iorfino et al, who state that “conclusions about the effects of specific treatments cannot be drawn”, McGorry in the accompanying editorial2 claims that findings “clearly illustrate what else is needed” — “more sustained, expert, and multidisciplinary care”. He uses the editorial to champion headspace and request yet more financial support. McGorry characterises the two‐thirds with persisting poor functioning as the “missing middle” for whom he advocates scaling up his model of care, developed for people with psychosis, to “be rapidly installed across the nation”, claiming “Countless lives and futures will be saved”. Given the uncertainty of the evidence, it is difficult to understand how such sweeping claims have survived the peer review process. Decisions on investment in mental health care should be based not on rhetoric, but on a rigorous and impartial review of the evidence and research to develop the evidence base.
Katharine A Wallis · Nicholas A Zwar · Paul P Glasziou
Social and occupational outcomes for young people who attend early intervention mental health services: a longitudinal study
In reply
Frank Iorfino · Elizabeth M Scott · Ian B Hickie
Social and occupational outcomes for young people who attend early intervention mental health services: a longitudinal study
In reply: In response to Wallis and colleagues,1 their interpretation of the Iorfino et al2 article is incorrect. Being fully acquainted with the youth mental health service described, I am clear that what was provided to most patients in the sample reported is in fact low intensity and primary care. Multiple publications on headspace, two independent evaluations3,4 (a third is in progress), and the huge national dataset routinely collected by headspace are also broadly consistent with the findings of this article. It is true, as Wallis and colleagues state, that in headspace, as in general practice more widely, there is a large subset of patients with multiple morbidity and more complex and persistent conditions. That is the whole point of the article. While most patients in primary care with medical complexity are generally able to access and secure tenure within the next tier of care (ie, specialist care), that is simply not the case for young people with mental ill health and mental illness. This leads to Wallis and colleagues’ critique of the solution that Iorfino et al proposed, and upon which I elaborated in my editorial.5 This solution — namely that platforms of multidisciplinary care with more secure tenure be established as a back‐up system — is pretty obvious and is a feature in all credible recent blueprints for reform. For young people aged 12–25years, this means expanding the diagnostic reach and national coverage of the six (soon to be eight) regional early psychosis platforms. Wallis et al describe my characterisation of such a proposal as “rhetoric”. In fact, the early psychosis model of care is supported by Cochrane level 1 evidence and three decades of worldwide experience and scaling up across many high income countries, including the United Kingdom, the United States, Canada, Denmark and Hong Kong. They are now the international standard of care for this group of patients. Indeed, the existing early psychosis programs funded by the federal government are producing functional outcomes as good or better than anywhere in the world, with high fidelity.6 They most assuredly save lives and futures. In any event, we can all agree that “decisions on investment in mental health care should be based not on rhetoric, but on a rigorous and impartial review of the evidence and research to develop the evidence base”. That is exactly the approach that my colleagues and I, and indeed the whole early intervention field, have always pursued, and continue to, as we expand the diagnostic coverage of these programs.
Patrick D McGorry
Surviving and thriving after breast cancer treatment
Christobel M Saunders · Lesley Stafford · Martha Hickey
Bariatric surgery: a call for greater access to coordinated surgical and specialist care in the public health system
Ahmad Aly · Michael L Talbot · Wendy A Brown
Systemic amyloidosis in a patient presenting with myopathy, peripheral oedema and proteinuria
Laura Bywater · Anthea C Gist · Rahul G Muthalaly · Joanna Loh · Ian Simpson · Anthony J White · Andy KH Lim
Better understanding of the scope and nature of LGBTQA+ religious conversion practices will support recovery
Jennifer Power · Timothy W Jones · Tiffany Jones · Nathan Despott · Maria Pallotta‐Chiarolli · Joel Anderson
Sodium–glucose cotransporter 2 inhibitors in type 1 diabetes: a missed opportunity for cardiovascular protection?
Jennifer R Snaith · Jerry R Greenfield